Showing results (51-60 of 77) with videos related to
Sort By:
Pageof 8
The American Journal of Psychiatry|December 1, 1977
A survey of tardive dyskinesia in psychiatric outpatientsG M Asnis, M A Leopold, R C Duvoisin, et al.European Journal of Pharmacology|October 22, 1985
Prevention of MPTP-induced neurotoxicity by AGN-1133 and AGN-1135, selective inhibitors of monoamine oxidase-BR E Heikkila, R C Duvoisin, J P Finberg, et al.Neurology|May 1, 1985
Neurophysiologic study of olivopontocerebellar atrophy with or without glutamate dehydrogenase deficiencyS Chokroverty, R C Duvoisin, R Sachdeo, et al.Annals of Neurology|July 1, 1988
Long-term duodenal infusion of levodopa for motor fluctuations in parkinsonismJ I Sage, S Trooskin, P K Sonsalla, et al.Annals of Neurology|March 1, 1990
A large kindred with autosomal dominant Parkinson's diseaseL I Golbe, G Di Iorio, V Bonavita, et al.Clinical Neuropharmacology|February 1, 1990
Clinically atypical expression of pathologically typical Lewy-body parkinsonismJ I Sage, D C Miller, L I Golbe, et al.Journal of Neurochemistry|January 1, 1985
Effects of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine and related compounds on the uptake of [3H]3,4-dihydroxyphenylethylamine and [3H]5-hydroxytryptamine in neostriatal synaptosomal preparationsR E Heikkila, S K Youngster, L Manzino, et al.Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1987
Computed tomographic findings in progressive supranuclear palsy: correlation with clinical gradeS M Schonfeld, L I Golbe, J I Sage, et al.Movement Disorders : Official Journal of the Movement Disorder Society|July 1, 1995
Binswanger's disease presenting as levodopa-responsive parkinsonism: clinicopathologic study of three casesM H Mark, J I Sage, A S Walters, et al.European Neurology|January 1, 1990
Steady plasma levodopa concentrations required for good clinical response to CR-4 in patients with 'on-off'D M McHale, J I Sage, P K Sonsalla, et al.Pageof 8